O’Melveny Client BGI-Shenzhen Receives Early Termination Of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of Complete Genomics, Inc.

January 07, 2013 BGI-Shenzhen and Complete Genomics, Inc. recently announced that they have received early termination of the Hart-Scott-Rodino waiting period from the Federal Trade Commission regarding BGI's proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete Genomics, Inc. O'Melveny & Myers LLP is acting as legal counsel to BGI-Shenzhen. For additional information, please see the companies’ January 7, 2013, press release.